{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:03:12Z","timestamp":1792803792433,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05975-7","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:05:44Z","timestamp":1779447944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of multimorbidity burden with outcomes after percutaneous coronary intervention: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaofu","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanfei","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"7","key":"5975_CR1","first-page":"e011540","volume":"15","author":"M Singh","year":"2022","unstructured":"Singh M, Gulati R, Lewis BR, Zhou Z, Alkhouli M, Friedman P, Bell MR. Multimorbidity and Mortality Models to Predict Complications Following Percutaneous Coronary Interventions. Circulation: Cardiovasc Interventions. 2022;15(7):e011540.","journal-title":"Circulation: Cardiovasc Interventions"},{"key":"5975_CR2","doi-asserted-by":"crossref","unstructured":"Zheng W, Huang X, Wang X, Suo M, Yan Y, Gong W, Ai H, Que B, Nie S. Impact of multimorbidity patterns on outcomes and treatment in patients with coronary artery disease. Eur Heart J Open. 2024;4(2):oeae009.","DOI":"10.1093\/ehjopen\/oeae009"},{"issue":"5","key":"5975_CR3","first-page":"345","volume":"4","author":"D Zhao","year":"2024","unstructured":"Zhao D, Wang Y, Wong ND, Wang J. Impact of Aging on Cardiovascular Diseases. JACC: Asia. 2024;4(5):345\u201358.","journal-title":"JACC: Asia"},{"key":"5975_CR4","doi-asserted-by":"crossref","unstructured":"Forman DE, Maurer MS, Boyd C, Brindis R, Salive ME, Horne FM, Bell SP, Fulmer T, Reuben DB, Zieman S et al. Multimorbidity in Older Adults With Cardiovascular Disease. JACC 2018, 71(19):2149\u20132161.","DOI":"10.1016\/j.jacc.2018.03.022"},{"key":"5975_CR5","doi-asserted-by":"crossref","unstructured":"Dunlay SM, Chamberlain AM. Multimorbidity in Older Patients with Cardiovascular Disease. Curr Cardiovasc risk Rep. 2016;10(1):1\u20139.","DOI":"10.1007\/s12170-016-0491-8"},{"issue":"7","key":"5975_CR6","doi-asserted-by":"publisher","first-page":"e061830","DOI":"10.1136\/bmjopen-2022-061830","volume":"12","author":"B Beska","year":"2022","unstructured":"Beska B, Mills GB, Ratcovich H, Wilkinson C, Damluji AA, Kunadian V. Impact of multimorbidity on long-term outcomes in older adults with non-ST elevation acute coronary syndrome in the North East of England: a multi-centre cohort study of patients undergoing invasive care. BMJ open. 2022;12(7):e061830.","journal-title":"BMJ open"},{"issue":"1","key":"5975_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12872-023-03636-7","volume":"24","author":"CLB Ho","year":"2024","unstructured":"Ho CLB, Si S, Brennan A, Briffa T, Stub D, Ajani A, Reid CM. Multimorbidity impacts cardiovascular disease risk following percutaneous coronary intervention: latent class analysis of the Melbourne Interventional Group (MIG) registry. BMC Cardiovasc Disord. 2024;24(1):66.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"5975_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jacc.2022.05.017","volume":"80","author":"G Giustino","year":"2022","unstructured":"Giustino G, Colombo A, Camaj A, Yasumura K, Mehran R, Stone GW, Kini A, Sharma SK. Coronary In-Stent Restenosis. JACC. 2022;80(4):348\u201372.","journal-title":"JACC"},{"issue":"23","key":"5975_CR9","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1093\/eurheartj\/ehaf167","volume":"46","author":"K Marx-Sch\u00fctt","year":"2025","unstructured":"Marx-Sch\u00fctt K, Cherney DZI, Jankowski J. Cardiovascular disease in chronic kidney disease. Eur Heart J. 2025;46(23):2148\u201360.","journal-title":"Eur Heart J"},{"key":"5975_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.avsg.2023.05.023","volume":"95","author":"SP Suarez Ferreira","year":"2023","unstructured":"Suarez Ferreira SP, Hall RP, Majumdar M, Goudot G, Jessula S, Bellomo T, Lee I, Kukreja N, Parmar G, Boada AE, et al. Atorvastatin Effect on Clopidogrel Efficacy in Patients with Peripheral Artery Disease. Ann Vasc Surg. 2023;95:74\u20139.","journal-title":"Ann Vasc Surg"},{"issue":"2","key":"5975_CR11","doi-asserted-by":"publisher","first-page":"e70258","DOI":"10.1111\/cns.70258","volume":"31","author":"X Huang","year":"2025","unstructured":"Huang X, Song J. Understanding Drug Interactions in Antiplatelet Therapy for Atherosclerotic Vascular Disease: A Systematic Review. CNS Neurosci Ther. 2025;31(2):e70258.","journal-title":"CNS Neurosci Ther"},{"issue":"11","key":"5975_CR12","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N. Cardiovascular Disease in Chronic Kidney Disease. Circulation. 2021;143(11):1157\u201372.","journal-title":"Circulation"},{"issue":"13","key":"5975_CR13","first-page":"1320","volume":"10","author":"E Mahmud","year":"2017","unstructured":"Mahmud E, Naghi J, Ang L, Harrison J, Behnamfar O, Pourdjabbar A, Reeves R, Patel M. Demonstration of the Safety and Feasibility of Robotically Assisted Percutaneous Coronary Intervention in Complex Coronary Lesions: Results of the CORA-PCI Study (Complex Robotically Assisted Percutaneous Coronary Intervention). JACC: Cardiovasc Interventions. 2017;10(13):1320\u20137.","journal-title":"JACC: Cardiovasc Interventions"},{"key":"5975_CR14","unstructured":"Charlson Me Fau -, Pompei P, Pompei P, Fau - Ales KL. Ales Kl Fau - MacKenzie CR, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of chronic diseases (0021-9681 (Print))."},{"issue":"9","key":"5975_CR15","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0300-8932(04)77204-8","volume":"57","author":"JE N\u00fa\u00f1ez","year":"2004","unstructured":"N\u00fa\u00f1ez JE, N\u00fa\u00f1ez E, F\u00e1cila L, Bertomeu V, Ll\u00e0cer A, Bod\u00ed V, Sanchis J, Sanju\u00e1n R, Blasco ML, Consuegra L, et al. [Prognostic value of Charlson comorbidity index at 30 days and 1 year after acute myocardial infarction]. Rev Esp Cardiol. 2004;57(9):842\u20139.","journal-title":"Rev Esp Cardiol"},{"issue":"4","key":"5975_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/heartjnl-2013-304588","volume":"100","author":"D Radovanovic","year":"2014","unstructured":"Radovanovic D, Seifert B, Urban P, Eberli FR, Rickli H, Bertel O, Puhan MA, Erne P. on behalf of the API: Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002\u20132012. Heart. 2014;100(4):288.","journal-title":"Heart"},{"key":"5975_CR17","doi-asserted-by":"crossref","unstructured":"Castiello DS, Calvelli P, Anniballo A, Romano LR, Polimeni A, Curcio A. The prognostic impact of beta blockers in ischemic heart failure: time for a paradigm shift?. 2026;31(1)41.","DOI":"10.1007\/s10741-026-10615-5"},{"issue":"22","key":"5975_CR18","doi-asserted-by":"publisher","first-page":"e012874","DOI":"10.1161\/JAHA.119.012874","volume":"8","author":"A Cai","year":"2019","unstructured":"Cai A, Dillon C, Hillegass WB, Beasley M, Brott BC, Bittner VA, Perry GJ, Halade GV, Prabhu SD, Limdi NA. Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention. J Am Heart Association. 2019;8(22):e012874.","journal-title":"J Am Heart Association"},{"issue":"1","key":"5975_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1477-7525-7-96","volume":"7","author":"KA Goldsmith","year":"2009","unstructured":"Goldsmith KA, Dyer MT, Schofield PM, Buxton MJ, Sharples LD. Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions. Health Qual Life Outcomes. 2009;7(1):96.","journal-title":"Health Qual Life Outcomes"},{"key":"5975_CR20","doi-asserted-by":"publisher","first-page":"117954681985405","DOI":"10.1177\/1179546819854059","volume":"13","author":"AE Rodriguez","year":"2019","unstructured":"Rodriguez AE, Larribau M, Fernandez-Pereira C. One-Year Follow-Up Results From the Observational, Multicenter, Prospective, and Controlled Registry: The WALTZ All-Comers Study. Clin Med Insights Cardiol. 2019;13:1179546819854059.","journal-title":"Clin Med Insights Cardiol"},{"issue":"3Part1","key":"5975_CR21","first-page":"390","volume":"3","author":"J Lee","year":"2023","unstructured":"Lee J, Kim M-J, Kim M, Park J, Kim H, Cho S, Choi Y, Lee J, Kim Ju H, Cha Sung J, et al. Validation of Academic Research Consortium for High Bleeding Risk Definition in East-Asian Patients. JACC: Asia. 2023;3(3Part1):390\u20139.","journal-title":"JACC: Asia"},{"key":"5975_CR22","doi-asserted-by":"publisher","first-page":"131572","DOI":"10.1016\/j.ijcard.2023.131572","volume":"395","author":"N Carabetta","year":"2024","unstructured":"Carabetta N, Siller-Matula JM, Boccuto F, Panuccio G, Indolfi C, Torella D, De Rosa S. Commissural alignment during TAVR reduces the risk of overlap to coronary ostia. Int J Cardiol. 2024;395:131572.","journal-title":"Int J Cardiol"},{"issue":"9","key":"5975_CR23","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","volume":"32","author":"P Libby","year":"2012","unstructured":"Libby P. Inflammation in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045\u201351.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"5975_CR24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"11","key":"5975_CR25","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","volume":"128","author":"PM Ridker","year":"2021","unstructured":"Ridker PM, Rane M. Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease. Circul Res. 2021;128(11):1728\u201346.","journal-title":"Circul Res"},{"issue":"11","key":"5975_CR26","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1113\/EP085567","volume":"101","author":"AC Newby","year":"2016","unstructured":"Newby AC. Metalloproteinase production from macrophages - a perfect storm leading to atherosclerotic plaque rupture and myocardial infarction. Exp Physiol. 2016;101(11):1327\u201337.","journal-title":"Exp Physiol"},{"issue":"5","key":"5975_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11883-012-0269-5","volume":"14","author":"AP 3rd Owens","year":"2012","unstructured":"Owens AP 3rd, Mackman N. Role of tissue factor in atherothrombosis. Curr Atheroscler Rep. 2012;14(5):394\u2013401.","journal-title":"Curr Atheroscler Rep"},{"key":"5975_CR28","doi-asserted-by":"crossref","unstructured":"Jiang HA-O, Wang H, Liang B, Sun L, Bai L. Prognostic implication of systemic inflammatory state on antiplatelet effect in patients after percutaneous coronary intervention for ST-elevation myocardial infarction: A retrospective cohort study. Medicine (1536\u20135964 (Electronic)). 2021;100(37):e27214.","DOI":"10.1097\/MD.0000000000027214"},{"issue":"5","key":"5975_CR29","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/01.HYP.31.5.1047","volume":"31","author":"GM Pieper","year":"1998","unstructured":"Pieper GM. Review of Alterations in Endothelial Nitric Oxide Production in Diabetes. Hypertension. 1998;31(5):1047\u201360.","journal-title":"Hypertension"},{"key":"5975_CR30","doi-asserted-by":"publisher","first-page":"919422","DOI":"10.3389\/fphys.2022.919422","volume":"13","author":"J Spiesshoefer","year":"2022","unstructured":"Spiesshoefer J, Regmi B, Ottaviani MM, Kahles F, Giannoni A, Borrelli C, Passino C, Macefield V, Dreher M. Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential. Front Physiol. 2022;13:919422.","journal-title":"Front Physiol"},{"issue":"1","key":"5975_CR31","doi-asserted-by":"publisher","first-page":"H135","DOI":"10.1152\/ajpheart.00908.2024","volume":"329","author":"ME Cho","year":"2025","unstructured":"Cho ME, Brunt VE, Shiu Y-T, Bunsawat K. Endothelial dysfunction in chronic kidney disease: a clinical perspective. Am J Physiol Heart Circ Physiol. 2025;329(1):H135\u201353.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"5975_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/CIRCRESAHA.120.314458","volume":"128","author":"S Zhao","year":"2021","unstructured":"Zhao S, Kusminski CM, Scherer PE. Adiponectin, Leptin and Cardiovascular Disorders. Circul Res. 2021;128(1):136\u201349.","journal-title":"Circul Res"},{"key":"5975_CR33","first-page":"e17","volume":"20","author":"E Bigagli","year":"2025","unstructured":"Bigagli E, Angelini J. Oral P2Y(12) Inhibitors: Victims or Perpetrators? A Focused Review on Pharmacokinetic. Clinically Relevant Drug Interact. 2025;20:e17.","journal-title":"Clinically Relevant Drug Interact"},{"issue":"9867","key":"5975_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(13)60108-7","volume":"381","author":"V Farooq","year":"2013","unstructured":"Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, Kappetein AP, Colombo A, Holmes DR Jr., Mack M, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet (London England). 2013;381(9867):639\u201350.","journal-title":"Lancet (London England)"},{"issue":"2","key":"5975_CR35","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","volume":"79","author":"WC Members","year":"2022","unstructured":"Members WC, Lawton Jennifer S, Tamis-Holland Jacqueline E, Bangalore S, Bates Eric R, Beckie Theresa M, Bischoff James M, Bittl John A, Cohen Mauricio G, DiMaio JM, et al. 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21\u2013129.","journal-title":"JACC"},{"issue":"18","key":"5975_CR36","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1161\/CIR.0000000000001289","volume":"150","author":"TM Brown","year":"2024","unstructured":"Brown TM, Pack QR, Aberegg E, Brewer LC, Ford YR, Forman DE, Gathright EC, Khadanga S, Ozemek C, Thomas RJ. Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2024;150(18):e328\u201347.","journal-title":"Circulation"},{"issue":"5","key":"5975_CR37","doi-asserted-by":"publisher","first-page":"e011160","DOI":"10.1161\/JAHA.118.011160","volume":"8","author":"SJ Al\u2019Aref","year":"2019","unstructured":"Al\u2019Aref SJ, Singh G, van Rosendael AR, Kolli KK, Ma X, Maliakal G, Pandey M, Lee BC, Wang J, Xu Z, et al. Determinants of In-Hospital Mortality After Percutaneous Coronary Intervention: A Machine Learning Approach. J Am Heart Association. 2019;8(5):e011160.","journal-title":"J Am Heart Association"},{"key":"5975_CR38","doi-asserted-by":"crossref","unstructured":"Alshahrani Nasser S, Hartley A, Howard J, Hajhosseiny R, Khawaja S, Seligman H, Akbari T, Alharbi Badr A, Bassett P, Al-Lamee R et al. Randomized Trial of Remote Assessment of Patients After an Acute Coronary Syndrome. JACC 2024, 83(23):2250\u20132259.","DOI":"10.1016\/j.jacc.2024.03.398"},{"issue":"12","key":"5975_CR39","doi-asserted-by":"publisher","first-page":"e14303","DOI":"10.1111\/eci.14303","volume":"54","author":"G Panuccio","year":"2024","unstructured":"Panuccio G, Carabetta N, Torella D, De Rosa S. Percutaneous coronary revascularization versus medical therapy in chronic coronary syndromes: an updated meta-analysis of randomized controlled trials. Eur J Clin Invest. 2024;54(12):e14303.","journal-title":"Eur J Clin Invest"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05975-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05975-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05975-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:29:51Z","timestamp":1784251791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05975-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5975"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05975-7","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"25 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this retrospective study was granted by the Medical Ethics Committee of Jinan No.5 People\u2019s Hospital (24-1-07). The study was conducted in accordance with the Declaration of Helsinki. Due to the retrospective nature of the study and the use of anonymized routinely collected clinical data, the requirement for written informed consent was waived by the ethics committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"606"}}